Keywords: ارزیابی جهانی محقق; Botulinum toxins; Clinical trial; AE; Adverse event; BoNT; Botulinum neurotoxin; CD; Cervical dystonia; CGRP; calcitonin gene-related peptide; CP; cerebral palsy; IGA; Investigator's Global Assessment; IL-6; Interleukin 6; MMP-1; Matrix metalloproteinase-
مقالات ISI ارزیابی جهانی محقق (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ارزیابی جهانی محقق; fixed combination; halobetasol; psoriasis; tazarotene; topical; AE; adverse event; BSA; body surface area; DLQI; Dermatology Life Quality Index; HP/TAZ; halobetasol propionate 0.01% plus tazarotene 0.045%; IGA; Investigator's Global Assessment; QoL; quali
Keywords: ارزیابی جهانی محقق; asimadoline; atopic dermatitis; emerging agents; fezakinumab; hypocholrous acid; omiganan; secukinumab; tapinarof; AD; atopic dermatitis; AE; adverse effect; AhR; aryl hydrocarbon receptor; AMP; antimicrobial peptide; EFA; essential fatty acids; HOCl; hyp
Keywords: ارزیابی جهانی محقق; clinical scale validation; dermatology; hair loss; scoring system; trichology; CI; confidence interval; FFA; frontal fibrosing alopecia; FFASS; Frontal Fibrosing Alopecia Severity Score; ICC; intraclass correlation coefficient; IGA; Investigator's Global
Keywords: ارزیابی جهانی محقق; Eczema; atopic dermatitis; atopic eczema; induction of remission; subclinical inflammation; long-term management; AD; Atopic dermatitis; EASI; Eczema Area Severity Index; IGA; Investigator's global assessment; PUVA; Psoralen plus UVA; RCT; Randomized cont
Dupilumab: A review of its use in the treatment of atopic dermatitis
Keywords: ارزیابی جهانی محقق; biologics; dupilumab; IL-4; IL-13; IL-4Rα; moderate-to-severe atopic dermatitis; systemic therapy; AD; atopic dermatitis; ADA; antidrug antibody; CCL; C-C motif chemokine ligand; CYP450; cytochrome P450; DLQI; Dermatology Life Quality Index; EASI; Eczema
Monoclonal antibodies against interleukin 13 and interleukin 31RA in development for atopic dermatitis
Keywords: ارزیابی جهانی محقق; atopic dermatitis; dipeptidyl peptidase-4; Eczema Area and Severity Index; interleukin; IL-31RA; Investigator's Global Assessment; Janus kinase; c-Jun N-terminal kinase; mitogen-activated protein kinase; oncostatin M receptor β; STAT signal transducer a
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
Keywords: ارزیابی جهانی محقق; anti-IL-17; anti-IL-17A; anti-IL-17F; bimekizumab; biologic therapy; clear or almost clear skin; dose ranging; efficacy; interleukin 17A; interleukin 17F; PASI90; PASI100; phase 2b; plaque psoriasis; randomized clinical trial; safety; AE; adverse event; I
Guidelines of care for the management of atopic dermatitis
Keywords: ارزیابی جهانی محقق; assessment scales; atopic dermatitis; biomarkers; clinical associations; criteria; diagnosis; risk factors; AAD; American Academy of Dermatology; AD; atopic dermatitis; ADHD; attention deficit hyperactivity disorder; CDLQI; Children's Dermatology Life Qu
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: A two-year study
Keywords: ارزیابی جهانی محقق; AD; atopic dermatitis; EASI; Eczema Area and Severity Index; IGA; Investigator's Global Assessment; NOS; not otherwise specified; NEC; not elsewhere classified; SEM; standard error of the mean; TBSA; total body surface area; UVA/B; ultraviolet A/B;